Retension Pharmaceuticals, Inc. RTSN
10.92 USD -0.67 (-5.80%)
Nov 5, 2026, 2:31 PM EST
10.73 Day range 11.80
9.66 52-week range 18.64
- YTD
- +3.73%
- 1 year
- +3.73%
- Market cap
- 91.00M
- EPS (ttm)
- -2.61
- YTD return
- +3.73%
- 1-year return
- +3.73%
- Volume
- 78.12K
- Avg volume
- 146.96K
- Open
- 11.33
- Previous close
- 11.60
- Day's range
- 10.73 – 11.80
- 52-week range
- 9.66 – 18.64
5m -0.84 (-7.14%)
Financials — quick view
RTSN Revenue — annual 0
RTSN Net income — annual -6.30M
RTSN EPS — annual -1.26
News
Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference 
Oppenheimer Initiates Coverage On Retension Pharmaceuticals with Outperform Rating, Announces Price Target of $50 
Guggenheim Initiates Coverage On Retension Pharmaceuticals with Buy Rating, Announces Price Target of $55 
Retension Pharmaceuticals Announces Pricing of Initial Public Offering
Your note
Sign in to keep a note on RTSN — it syncs with the Stock Master app.